arrow
C

Clare Cutland

University of the Witwatersrand
H指数:56
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Persistence of Antibodies at Three, Four and Five Years of Age to Ten-valent Pneumococcal Polysaccharide Protein D-conjugate Vaccine in South African Children According to HIV Status

根据HIV感染状况,南非儿童接种十价肺炎球菌多糖-蛋白D结合疫苗后3岁、4岁和5岁时的抗体持久性

2026-02-010
PRE
Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers

纵向Meta-cohort研究方案:采用系统生物学方法识别疫苗安全性生物标志物

Vaccine
IF3.5
2025-07-260
OA
Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia

撒哈拉以南非洲和南亚地区孕妇中乙型肝炎病毒感染的患病率及脐带血乙型肝炎表面抗原阳性新生儿的流行情况

2025-06-110
OA
Sero-epidemiology of measles immunoglobulin G antibodies among newborns from South-East Asia and sub-Saharan Africa: an observational, multicenter study

东南亚和撒哈拉以南非洲新生儿中麻疹免疫球蛋白G抗体的血清流行病学:一项观察性、多中心研究

2025-05-010
OAAI
Epidemiology of Group B Streptococcus: Maternal Colonization and Infant Disease in Kampala, Uganda
2025-04-010
OAAI
Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review (vol 18, 100464, 2024)

定义和报告比较性母体疫苗研究中的特殊关注不良事件:一项系统综述(卷18,100464,2024)

vaccine
IF2.2
2025-02-010
OAAI
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response

高分辨率非洲HLA资源揭示了疫苗反应背后的HLA-DRB1表达效应

2024-05-130
OAAI
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19

ChAdOx1 nCoV-19 (AZD1222) 疫苗诱导的Fc受体结合轨道对新型冠状病毒肺炎的敏感性不同

2023-06-157
OAAI
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomisedtrial

10价和13价肺炎球菌结合疫苗的单次初免和加强剂量与南非儿童肺炎链球菌定植: 一项单中心、开放标签、随机试验

2023-05-014
OAAI
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial

ChAdOx1 nCoV-19 (AZD1222) 疫苗和针对omicron BA.1和BA.4变体的杂交体液免疫在疫苗接种后6个月的持久性 (COV005): 一项随机1b-2a期试验的事后分析

2023-03-0114
OAAI
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

触手可及的呼吸道合胞病毒预防: 疫苗和单克隆抗体的前景

2023-01-01219
OAAI
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa
AIDS
IF3.1
2022-10-215
OA
Effectiveness of Influenza Vaccination of Pregnant Women for Prevention of Maternal and Early Infant Influenza-Associated Hospitalizations in South Africa: A Prospective Test-Negative Study

南非孕妇流感疫苗接种预防母婴流感相关住院的有效性: 一项前瞻性测试阴性研究

2022-10-194
OAAI